Cargando…
Terbinafin 1% Cream and Ketoconazole 2% Cream in the Treatment of Pityriasis Versicolor: A randomized comparative clinical trial
Objective: To make a comparison between terbinafine 1% cream and ketoconazole 2% cream in the treatment of pityriasis versicolor. Methods: This randomized single blind study included 110 patients with clinical diagnosis of pityriasis versicolor and positive mycological test for Malassezia furfur. Th...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Professional Medical Publicaitons
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320714/ https://www.ncbi.nlm.nih.gov/pubmed/25674122 http://dx.doi.org/10.12669/pjms.306.5509 |
_version_ | 1782356167912062976 |
---|---|
author | Rad, Farrokh Nik-Khoo, Bahram Yaghmaee, Roxana Gharibi, Fardin |
author_facet | Rad, Farrokh Nik-Khoo, Bahram Yaghmaee, Roxana Gharibi, Fardin |
author_sort | Rad, Farrokh |
collection | PubMed |
description | Objective: To make a comparison between terbinafine 1% cream and ketoconazole 2% cream in the treatment of pityriasis versicolor. Methods: This randomized single blind study included 110 patients with clinical diagnosis of pityriasis versicolor and positive mycological test for Malassezia furfur. The patients were randomly assigned to two groups. Group 1 used terbinafine cream and group 2 applied ketoconazole cream on the skin lesions for two weeks. Each group consisted of 55 patients. Clinical and mycological examinations were performed at baseline, at the end of the 2(nd), 4(th) and 8(th) week of starting the treatment regimens. Results: At the end of the 2(nd) week we achieved cure rates of 72% and 64.3% for group 1 and group 2 respectively. At the end of the 4(th) week the respective cure rates for group 1 and group 2 were 81.2% and 69%, and at the end of the 8(th) week 70.8% of the patients in group 1 and 61.9% of the patients in group 2 were cured. Conclusion: The results of this study showed no significant statistical differences between the two groups in regard to cure and recurrence rates. But the numbers of cured patients were higher and recurrent cases were lower in group 1. |
format | Online Article Text |
id | pubmed-4320714 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Professional Medical Publicaitons |
record_format | MEDLINE/PubMed |
spelling | pubmed-43207142015-02-11 Terbinafin 1% Cream and Ketoconazole 2% Cream in the Treatment of Pityriasis Versicolor: A randomized comparative clinical trial Rad, Farrokh Nik-Khoo, Bahram Yaghmaee, Roxana Gharibi, Fardin Pak J Med Sci Original Article Objective: To make a comparison between terbinafine 1% cream and ketoconazole 2% cream in the treatment of pityriasis versicolor. Methods: This randomized single blind study included 110 patients with clinical diagnosis of pityriasis versicolor and positive mycological test for Malassezia furfur. The patients were randomly assigned to two groups. Group 1 used terbinafine cream and group 2 applied ketoconazole cream on the skin lesions for two weeks. Each group consisted of 55 patients. Clinical and mycological examinations were performed at baseline, at the end of the 2(nd), 4(th) and 8(th) week of starting the treatment regimens. Results: At the end of the 2(nd) week we achieved cure rates of 72% and 64.3% for group 1 and group 2 respectively. At the end of the 4(th) week the respective cure rates for group 1 and group 2 were 81.2% and 69%, and at the end of the 8(th) week 70.8% of the patients in group 1 and 61.9% of the patients in group 2 were cured. Conclusion: The results of this study showed no significant statistical differences between the two groups in regard to cure and recurrence rates. But the numbers of cured patients were higher and recurrent cases were lower in group 1. Professional Medical Publicaitons 2014 /pmc/articles/PMC4320714/ /pubmed/25674122 http://dx.doi.org/10.12669/pjms.306.5509 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Rad, Farrokh Nik-Khoo, Bahram Yaghmaee, Roxana Gharibi, Fardin Terbinafin 1% Cream and Ketoconazole 2% Cream in the Treatment of Pityriasis Versicolor: A randomized comparative clinical trial |
title | Terbinafin 1% Cream and Ketoconazole 2% Cream in the Treatment of Pityriasis Versicolor: A randomized comparative clinical trial |
title_full | Terbinafin 1% Cream and Ketoconazole 2% Cream in the Treatment of Pityriasis Versicolor: A randomized comparative clinical trial |
title_fullStr | Terbinafin 1% Cream and Ketoconazole 2% Cream in the Treatment of Pityriasis Versicolor: A randomized comparative clinical trial |
title_full_unstemmed | Terbinafin 1% Cream and Ketoconazole 2% Cream in the Treatment of Pityriasis Versicolor: A randomized comparative clinical trial |
title_short | Terbinafin 1% Cream and Ketoconazole 2% Cream in the Treatment of Pityriasis Versicolor: A randomized comparative clinical trial |
title_sort | terbinafin 1% cream and ketoconazole 2% cream in the treatment of pityriasis versicolor: a randomized comparative clinical trial |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320714/ https://www.ncbi.nlm.nih.gov/pubmed/25674122 http://dx.doi.org/10.12669/pjms.306.5509 |
work_keys_str_mv | AT radfarrokh terbinafin1creamandketoconazole2creaminthetreatmentofpityriasisversicolorarandomizedcomparativeclinicaltrial AT nikkhoobahram terbinafin1creamandketoconazole2creaminthetreatmentofpityriasisversicolorarandomizedcomparativeclinicaltrial AT yaghmaeeroxana terbinafin1creamandketoconazole2creaminthetreatmentofpityriasisversicolorarandomizedcomparativeclinicaltrial AT gharibifardin terbinafin1creamandketoconazole2creaminthetreatmentofpityriasisversicolorarandomizedcomparativeclinicaltrial |